Product News

Share this article:

Forest Laboratories and Cypress Bioscience launched Savella, a selective serotonin and norepinephrine dual reuptake inhibitor, for fibromyalgia. The product will be available in drug stores April 28.

 

Sanofi-Aventis launched Apidra SoloSTAR, an insulin pen, indicated for adults and children 4 years and older, with type 1 diabetes or adults with type 2 diabetes.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters